4//SEC Filing
Snyder Mark Howard 4
Accession 0001415889-25-004240
CIK 0001159036other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:11 PM ET
Size
13.6 KB
Accession
0001415889-25-004240
Insider Transaction Report
Form 4
Snyder Mark Howard
SVP, CHIEF LEGAL OFFICER
Transactions
- Award
Performance Stock Units
2025-02-12+6,050→ 17,409 totalExercise: $0.00→ Common Stock (6,050 underlying) - Award
Performance Stock Units
2025-02-12+4,698→ 7,365 totalExercise: $0.00→ Common Stock (4,698 underlying) - Award
Performance Stock Unit
2025-02-12+7,269→ 7,269 totalExercise: $0.00→ Common Stock (7,269 underlying) - Award
Performance Stock Units
2025-02-12+30,050→ 30,050 totalExercise: $0.00→ Common Stock (30,050 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2022 that included a performance measurement period ending December 31, 2024. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2024. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2024. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001902866
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:11 PM ET
- Size
- 13.6 KB